← Open Payments lookup

HELENA IN'T VELD: Open Payments

NPI 1982071429 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,427 in 68 payments from 14 companies in 2025. Trend: 2023 $18,347 · 2024 $22,576 · 2025 $8,427

Honoraria: $5,000Food & beverage: $1,675Consulting: $1,156Travel & lodging: $542Education: $54
CompanyPaymentsAmount
QOL Medical, LLC19$5,902
Takeda Pharmaceuticals U.S.A., Inc.1$1,156
Janssen Biotech, Inc.11$427
ABBVIE INC.12$268
Aimmune Therapeutics, Inc.5$159
Madrigal Pharmaceuticals3$110
GENZYME CORPORATION3$110
PFIZER INC.3$84
Ardelyx, Inc.3$61
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38

Products named: Sucraid, TREMFYA, RINVOQ, VOWST, REZDIFFRA, DUPIXENT, VELSIPITY, IBSRELA.

Industry payments across AZ — which companies pay providers there.